Document is current
Any future updates will be listed below
-
Authors
Lee, Yujin
Zalewski, Dominik
Oleksy, Piotr
Wylęgała, Edward
Orski, Michał
Lee, Jiwon
Kim, Sunji
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct06176963 at ClinicalTrials.govDocuments that mention this clinical trial
Usability of the SB11 Pre-filled Syringe (PFS) in Patients with Retinal Diseases
https://doi.org/10.1007/s12325-024-02937-3
-
Funding
Funding for this research was provided by:
Samsung Bioepis
- License Information
-
More Information
Article History
Received: 2 May 2024
Accepted: 21 June 2024
First Online: 8 July 2024
Declarations
:
: Yujin Lee, Jiwon Lee, and Sunji Kim are employees of Samsung Bioepis Co., Ltd. Edward Wylęgała obtained honoraria for lectures from Bayer, Roche, Alfa Sigma, Allergan, Zeiss, and Thea, and is part of the advisory board of Allergan.
: This study was conducted in compliance with International Council for Harmonization and Good Clinical Practice guidelines and the Declaration of Helsinki. Informed consent was obtained from each patient before entering the study. The study and clinical study protocol, informed consent forms (ICFs), and other applicable documents were reviewed and approved by an independent ethics committee (IEC) or Institutional Review Board (IRB) for each study center.
